Member Login
ADAPT
Adipokines as Drug Targets to Combat Adverse Effects of Excess Adipose Tissue
Welcome to the ADAPT Homepage
The work in this project is supported by the European Community’s 7th Framework
Programme under the call FP7-HEALTH-2007-A, SP-1 Cooperation, with contract no. HEALTH-F2-2008-201100. Coordinator: Juergen Eckel, German Diabetes Center
ADAPT is an EC-funded collaborative project of top European laboratories focusing on adipose tissue as a major endocrine organ. The major goal of this project is to identify novel or existing adipocytokines as drug targets that could be used to reverse obesity-associated inflammation and adverse reactions related to excess fat. The mustidisciplinary ADAPT consortium involves 11 partners and integrates basic and clinical science, bioinformatics, and in silico drug design. ADAPT is an inter-European collaborative network involving partners from Germany, Sweden, France and the Czech Republic.
If you are interested in obtaining further information about ADAPT, please contact the coordinator.
News
The European Union has granted a total of 3 Mio Euro for a cooperational research project...